Trial · NCT03506724
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to Achieve Non Severe Range Blood Pressure | Intravenous Labetalol | 10 | Inter-Quartile Range 10 to 20 | minutes | |
| Time to Achieve Non Severe Range Blood Pressure | Oral Nifedipine | 20 | Inter-Quartile Range 20 to 30 | minutes | |
| Number of Participants to Achieve Non Severe Range Blood Pressure | Intravenous Labetalol | White, Asian, and Hispanic | 33 | Participants | |
| Number of Participants to Achieve Non Severe Range Blood Pressure | Oral Nifedipine | White, Asian, and Hispanic | 31 | Participants | |
| Number of Participants to Achieve Non Severe Range Blood Pressure | Intravenous Labetalol | Black | 18 | Participants | |
| Number of Participants to Achieve Non Severe Range Blood Pressure | Oral Nifedipine | Black | 22 | Participants | |
| Number of Participants With Medication Side Effects | Intravenous Labetalol | Headache | 6 | Participants | |
| Number of Participants With Medication Side Effects | Oral Nifedipine | Headache | 10 | Participants | |
| Number of Participants With Medication Side Effects | Intravenous Labetalol | Nausea | 3 | Participants | |
| Number of Participants With Medication Side Effects | Oral Nifedipine | Nausea | 7 | Participants | |
| Number of Participants With Medication Side Effects | Intravenous Labetalol | Vomiting | 2 | Participants | |
| Number of Participants With Medication Side Effects | Oral Nifedipine | Vomiting | 3 | Participants | |
| Number of Participants With Medication Side Effects | Intravenous Labetalol | Dizziness | 8 | Participants | |
| Number of Participants With Medication Side Effects | Oral Nifedipine | Dizziness | 4 | Participants | |
| Number of Participants With Medication Side Effects | Intravenous Labetalol | Flushing | 7 | Participants | |
| Number of Participants With Medication Side Effects | Oral Nifedipine | Flushing | 7 | Participants | |
| Number of Participants With Medication Side Effects | Intravenous Labetalol | Any of the above | 18 | Participants | |
| Number of Participants With Medication Side Effects | Oral Nifedipine | Any of the above | 15 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03506724/results